Does pregabalin offer potential as a first-line therapy for generalized anxiety disorder? A meta-analysis of efficacy, safety, and cost-effectiveness - Cardoner, N.; Gutiérrez-Rojas, L.; Saiz, P.; Lahera, G.; Álvarez-Mon, M.Á.; Alonso Ortega, P.; Pérez-Páramo, M. (Frontiers in Pharmacology, 2025)